GBA Presents: RADIO SAVANT-!

Intensity Therapeutics' INT230-6 shows potential in metastatic sarcoma survival 07:08 INTS Intensity Therapeutics announced that data from its open-label phase 1/2 study of novel lead asset, INT230-6, as a monotherapy or in combination with ipilimumab in adult subjects with metastatic sarcomas, will be presented at the Connective Tissue Oncology Society Annual Meeting in Vancouver. Dosing with INT230-6 resulted in a median overall survival of 715 days vs. 205 days on historical sarcoma control. "Preliminary data suggests that INT230-6, as a monotherapy or in combination with the immune checkpoint blocker ipilimumab, demonstrates direct tumor killing in soft tissue sarcoma (STS) and elicits an anti-cancer immune response within the injected tumor," stated principal investigator Matthew Ingham. "To date, INT230-6 treatment related adverse events are mostly low grade and the drug is well-tolerated either as a monotherapy or in combination with ipilimumab. Additionally, in patients who had 40% or more of their tumor burden treated with INT230-6, an exploratory analysis showed that overall survival was improved when compared to historical benchmarks for this patient population." CEO Lewis Bender added, "The compelling safety and efficacy results from use of our drug in treating such a deadly and hard-to-treat cancer as soft tissue sarcomas underscore the potential of this treatment. The promising data supports our belief that INT230-6 could show clinical benefit with lower levels of off-target side effects compared to standard chemotherapies. We have designed a randomized phase 3 trial protocol to evaluate INT230-6 versus standard of care in patients with advanced soft tissue sarcomas and look forward to initiation of the study."
 
Stoney I'm in Foot Locker @$32.20 for earnings.
Thoughts?
FL--->+17%
:D:D:D

★★★★★★★★★★★★★★
HE DID IT AGAIN!!!
★★★★★★★★★★★★
#1 FOR A REASON


_________________________________________

STONEY!!!!
DON'T YOU REGRET TELLING EVERYONE TO GET OUT AT 3750 ON THE S&P?:p:cool::cool::cool::cool:
 
Foot Locker stock runs nearly 20% higher on raised full-year forecasts
Nov. 18, 2022 7:11 AM ETFoot Locker, Inc. (FL)
image_1349963996.jpg


Dig the ugly socks! that's my style. High & Ugly.
 
Oneof the funny things is when war broke out Trump immediately said Vlad was smart and the war was a good move and blah blah blah... 2 days later I shit you not complete change in view and the war is genocide... That's after his daughter got to him.

The Great war planer how would Trump attack Russia.

Trump said many times over that the war would never have happened if he were still president; and even called for the U.S. to attack Russia but make it look like it was actually China — by flying American planes with a Chinese flag on the side.

"And then we say, 'China did it,' " Trump told Republican donors Saturday in New Orleans, according to a recording obtained by The Washington Post. " 'We didn't do it — China did it,' and then they start fighting with each other and we sit back and watch." :D

The guy is a fucking child.

Now just for laughs I wonder if Trump's list of lies is as long as his Russian written list of accomplishments... remind me to look that one up later---
Dude... quit letting Trump live rent free in your head.
Move on. He had some good policies. Maybe he had some bad ones... so what. But your brain is too binary. You lack critical thought. That's not good Stoney.
 
Back
Top